Publications by authors named "Allen Reha"

Claim this Profile
D
Development of VNX-101, an adeno-associated virus with less immunogenicity and efficient long-term expression of a CD19 T cell engager.
Mark A Currier, Allen Reha, Brian Hutzen, Pin-Yi Wang, Chun-Yu Chen

Mol Ther Methods Clin Dev· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wound closure in epidermolysis bullosa: data from the vehicle arm of the phase 3 ESSENCE Study.
Dedee F Murrell, Amy S Paller, Christine Bodemer, John Browning, Milos Nikolic, Allen Reha

Orphanet J Rare Dis· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and tolerability of the investigational topical cream SD-101 (6% allantoin) in patients with epidermolysis bullosa: a phase 3, randomized, double-blind, vehicle-controlled trial (ESSENCE study).
Amy S Paller, John Browning, Milos Nikolic, Christine Bodemer, Dedee F Murrell, Allen Reha

Orphanet J Rare Dis· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The challenges of living with and managing epidermolysis bullosa: insights from patients and caregivers.
Anna L Bruckner, Michael Losow, Jayson Wisk, Nita Patel, Allen Reha

Orphanet J Rare Dis· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ataluren treatment of patients with nonsense mutation dystrophinopathy.
Katharine Bushby, Richard Finkel, Brenda Wong, Richard Barohn, Craig Campbell, Allen Reha

Muscle Nerve· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2a study of ataluren-mediated dystrophin production in patients with nonsense mutation Duchenne muscular dystrophy.
Richard S Finkel, Kevin M Flanigan, Brenda Wong, Carsten Bönnemann, Jacinda Sampson, Allen Reha

PLoS One· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 6-minute walk test and other clinical endpoints in duchenne muscular dystrophy: reliability, concurrent validity, and minimal clinically important differences from a multicenter study.
Craig M McDonald, Erik K Henricson, R Ted Abresch, Julaine Florence, Michelle Eagle, Allen Reha

Muscle Nerve· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 6-minute walk test and other endpoints in Duchenne muscular dystrophy: longitudinal natural history observations over 48 weeks from a multicenter study.
Craig M McDonald, Erik K Henricson, R Ted Abresch, Julaine M Florence, Michelle Eagle, Allen Reha

Muscle Nerve· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corticosteroids in Duchenne muscular dystrophy: major variations in practice.
Robert C Griggs, Barbara E Herr, Allen Reha, Gary Elfring, Leone Atkinson

Muscle Nerve· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Percent-predicted 6-minute walk distance in duchenne muscular dystrophy to account for maturational influences.
Erik Henricson, Richard Abresch, Jay J Han, Alina Nicorici, Erica Goude Keller, Allen Reha

PLoS Curr· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ambulatory quantitative waking and sleeping cough assessment in patients with cystic fibrosis.
Eitan Kerem, Michael Wilschanski, Nilsen L Miller, Thea Pugatsch, Tali Cohen, Allen Reha

J Cyst Fibros· May 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 6-minute walk test in Duchenne/Becker muscular dystrophy: longitudinal observations.
Craig M McDonald, Erik K Henricson, Jay J Han, R Ted Abresch, Alina Nicorici, Allen Reha

Muscle Nerve· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ataluren (PTC124) induces cystic fibrosis transmembrane conductance regulator protein expression and activity in children with nonsense mutation cystic fibrosis.
Isabelle Sermet-Gaudelus, Kris De Boeck, Georges J Casimir, François Vermeulen, Teresinha Leal, Allen Reha

Am J Respir Crit Care Med· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy.
Craig M McDonald, Erik K Henricson, Jay J Han, R Ted Abresch, Alina Nicorici, Allen Reha

Muscle Nerve· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis